位置:首页 > 蛋白库 > SOX18_MOUSE
SOX18_MOUSE
ID   SOX18_MOUSE             Reviewed;         377 AA.
AC   P43680; Q3UND6; Q9EQ73;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   10-OCT-2002, sequence version 3.
DT   03-AUG-2022, entry version 164.
DE   RecName: Full=Transcription factor SOX-18;
GN   Name=Sox18; Synonyms=Sox-18;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=BALB/cJ; TISSUE=Heart muscle;
RX   PubMed=7665083; DOI=10.1016/0378-1119(95)00280-j;
RA   Dunn T.L., Mynett-Johnson L., Wright E.M., Hosking B.M., Koopman P.A.,
RA   Muscat G.E.O.;
RT   "Sequence and expression of Sox-18 encoding a new HMG-box transcription
RT   factor.";
RL   Gene 161:223-225(1995).
RN   [2]
RP   SEQUENCE REVISION.
RA   Dunn T.L.;
RL   Submitted (NOV-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11130989; DOI=10.1007/s003350010216;
RA   Pennisi D.J., James K.M., Hosking B.M., Muscat G.E., Koopman P.;
RT   "Structure, mapping, and expression of human SOX18.";
RL   Mamm. Genome 11:1147-1149(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:BAE25811.1};
RC   TISSUE=Lung {ECO:0000312|EMBL:BAE25811.1};
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE OF 83-142.
RC   STRAIN=BALB/cJ; TISSUE=Heart muscle;
RA   Layfield R., Mynett-Johnson L., Yarwood P.J., Muscat G.E.O., Koopman P.A.,
RA   Hume D.A.;
RL   Submitted (FEB-1994) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   FUNCTION.
RX   PubMed=7651823; DOI=10.1093/nar/23.14.2626;
RA   Hosking B.M., Muscat G.E.O., Koopman P.A., Dowhan D.H., Dunn T.L.;
RT   "Trans-activation and DNA-binding properties of the transcription factor,
RT   Sox-18.";
RL   Nucleic Acids Res. 23:2626-2628(1995).
RN   [8]
RP   FUNCTION, AND MISCELLANEOUS.
RX   PubMed=11094083; DOI=10.1128/mcb.20.24.9331-9336.2000;
RA   Pennisi D., Bowles J., Nagy A., Muscat G., Koopman P.;
RT   "Mice null for sox18 are viable and display a mild coat defect.";
RL   Mol. Cell. Biol. 20:9331-9336(2000).
RN   [9]
RP   FUNCTION, DISEASE, AND DEVELOPMENTAL STAGE.
RX   PubMed=10742113; DOI=10.1038/74301;
RA   Pennisi D., Gardner J., Chambers D., Hosking B., Peters J., Muscat G.,
RA   Abbott C., Koopman P.;
RT   "Mutations in Sox18 underlie cardiovascular and hair follicle defects in
RT   ragged mice.";
RL   Nat. Genet. 24:434-437(2000).
RN   [10]
RP   FUNCTION, INTERACTION WITH MEF2C, AND SUBCELLULAR LOCATION.
RX   PubMed=11554755; DOI=10.1006/bbrc.2001.5589;
RA   Hosking B.M., Wang S.C., Chen S.L., Penning S., Koopman P., Muscat G.E.;
RT   "SOX18 directly interacts with MEF2C in endothelial cells.";
RL   Biochem. Biophys. Res. Commun. 287:493-500(2001).
RN   [11]
RP   FUNCTION, DISEASE, AND INTERACTION WITH MEF2C.
RX   PubMed=12748961; DOI=10.1002/gene.10190;
RA   James K., Hosking B., Gardner J., Muscat G.E., Koopman P.;
RT   "Sox18 mutations in the ragged mouse alleles ragged-like and opossum.";
RL   Genesis 36:1-6(2003).
RN   [12]
RP   FUNCTION.
RX   PubMed=16895970; DOI=10.1242/jcs.03081;
RA   Matsui T., Kanai-Azuma M., Hara K., Matoba S., Hiramatsu R., Kawakami H.,
RA   Kurohmaru M., Koopman P., Kanai Y.;
RT   "Redundant roles of Sox17 and Sox18 in postnatal angiogenesis in mice.";
RL   J. Cell Sci. 119:3513-3526(2006).
RN   [13]
RP   FUNCTION, DISEASE, DEVELOPMENTAL STAGE, AND MISCELLANEOUS.
RX   PubMed=18931657; DOI=10.1038/nature07391;
RA   Francois M., Caprini A., Hosking B., Orsenigo F., Wilhelm D., Browne C.,
RA   Paavonen K., Karnezis T., Shayan R., Downes M., Davidson T., Tutt D.,
RA   Cheah K.S., Stacker S.A., Muscat G.E., Achen M.G., Dejana E., Koopman P.;
RT   "Sox18 induces development of the lymphatic vasculature in mice.";
RL   Nature 456:643-647(2008).
RN   [14]
RP   FUNCTION, AND DISEASE.
RX   PubMed=19429912; DOI=10.1093/hmg/ddp219;
RA   Downes M., Francois M., Ferguson C., Parton R.G., Koopman P.;
RT   "Vascular defects in a mouse model of hypotrichosis-lymphedema-
RT   telangiectasia syndrome indicate a role for SOX18 in blood vessel
RT   maturation.";
RL   Hum. Mol. Genet. 18:2839-2850(2009).
RN   [15] {ECO:0007744|PDB:4Y60}
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 77-155 IN COMPLEX WITH DNA,
RP   FUNCTION, AND DOMAIN.
RX   PubMed=26939885; DOI=10.1093/nar/gkw130;
RA   Klaus M., Prokoph N., Girbig M., Wang X., Huang Y.H., Srivastava Y.,
RA   Hou L., Narasimhan K., Kolatkar P.R., Francois M., Jauch R.;
RT   "Structure and decoy-mediated inhibition of the SOX18/Prox1-DNA
RT   interaction.";
RL   Nucleic Acids Res. 44:3922-3935(2016).
CC   -!- FUNCTION: Transcriptional activator that binds to the consensus
CC       sequence 5'-AACAAAG-3' in the promoter of target genes and plays an
CC       essential role in embryonic cardiovascular development and
CC       lymphangiogenesis (PubMed:7651823, PubMed:10742113, PubMed:12748961,
CC       PubMed:18931657, PubMed:19429912, PubMed:26939885). Activates
CC       transcription of PROX1 and other genes coding for lymphatic endothelial
CC       markers (PubMed:18931657, PubMed:26939885). Plays an essential role in
CC       triggering the differentiation of lymph vessels, but is not required
CC       for the maintenance of differentiated lymphatic endothelial cells
CC       (PubMed:18931657). Plays an important role in postnatal angiogenesis,
CC       where it is functionally redundant with SOX17 (PubMed:16895970).
CC       Interaction with MEF2C enhances transcriptional activation
CC       (PubMed:11554755). Besides, required for normal hair development
CC       (PubMed:11094083, PubMed:12748961). {ECO:0000269|PubMed:10742113,
CC       ECO:0000269|PubMed:11094083, ECO:0000269|PubMed:11554755,
CC       ECO:0000269|PubMed:12748961, ECO:0000269|PubMed:16895970,
CC       ECO:0000269|PubMed:18931657, ECO:0000269|PubMed:19429912,
CC       ECO:0000269|PubMed:26939885, ECO:0000269|PubMed:7651823}.
CC   -!- SUBUNIT: Interacts (via C-terminus) with MEF2C (via MADS box).
CC       {ECO:0000269|PubMed:11554755, ECO:0000269|PubMed:12748961}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00267,
CC       ECO:0000269|PubMed:11554755}.
CC   -!- TISSUE SPECIFICITY: Detected in adult lung, heart and skeletal muscles.
CC       {ECO:0000269|PubMed:7665083}.
CC   -!- DEVELOPMENTAL STAGE: Detected at 7.5 and 8.0 dpc in the allantois and
CC       blood islands of the yolk sac, and in cells fated to become the
CC       endocardium. At 8.5 dpc, detected in the allantois and the nascent
CC       vasculature of the yolk sac, the paired dorsal aortae and heart
CC       (PubMed:10742113). At 9.5 to 11.0 dpc, detected in endothelial cells of
CC       the paired dorsal aortae, in intersomitic vessels and in a network of
CC       smaller vessels in head and trunc mesenchyme, and in endothelial cells
CC       lining the dorsolateral sector of the cardinal vein (PubMed:10742113,
CC       PubMed:18931657). At 10.5 dpc, detected inprecursors of the lymphatic
CC       vasculature (PubMed:18931657). At 12.5 dpc, detected in branching
CC       vessels and in nascent vibrissae follicles. Detected in vibrissae
CC       follicles and pelage follicles at 14.0 dpc (PubMed:10742113). Detected
CC       in primary lymph sacs at 13.5 dpc, but is not detected in embryonic or
CC       adult lymph vessels (PubMed:18931657). {ECO:0000269|PubMed:10742113,
CC       ECO:0000269|PubMed:18931657}.
CC   -!- DOMAIN: Binds target DNA via the HMG box domain.
CC       {ECO:0000269|PubMed:26939885}.
CC   -!- DOMAIN: The 9aaTAD motif is a transactivation domain present in a large
CC       number of yeast and animal transcription factors.
CC       {ECO:0000250|UniProtKB:P35713}.
CC   -!- DISEASE: Note=Defects in this protein are the cause of the ragged,
CC       ragged-like and opossum phenotypes (PubMed:10742113, PubMed:12748961,
CC       PubMed:18931657, PubMed:19429912). In all these, missense mutations
CC       give rise to a truncated protein that retains DNA-binding ability, but
CC       lacks regions required for transcription activation (PubMed:10742113,
CC       PubMed:12748961). Homozygous ragged and ragged-like mice are almost
CC       completely naked, display prenatal edema and frequently die in utero or
CC       shortly after birth. Heterozygous ragged and ragged-like mice are
CC       mostly viable, but have a thin, ragged coat (PubMed:12748961).
CC       Homozygous opossum mice display no visible phenotype up to 11.5 dpc
CC       (PubMed:19429912). From 12.5 dpc onwards, mutant embryos display
CC       enlarged surface microvasculature and severe subcutaneaous edema,
CC       followed by vascular rupture and hemorrhage beginning at 13.5 dpc
CC       (PubMed:18931657, PubMed:19429912). All die shortly after 14.5 dpc
CC       (PubMed:12748961, PubMed:18931657, PubMed:19429912). Heterozygous
CC       opossum mice are almost completely naked, display prenatal edema and
CC       frequently die in utero or shortly after birth (PubMed:12748961).
CC       Heterozygous opossum mice display defects in development and patterning
CC       of the lymph vessels (PubMed:18931657). {ECO:0000269|PubMed:10742113,
CC       ECO:0000269|PubMed:12748961, ECO:0000269|PubMed:18931657,
CC       ECO:0000269|PubMed:19429912}.
CC   -!- MISCELLANEOUS: Deletion of the DNA-binding and the C-terminal
CC       transcription activation domains causes no visible phenotype, excepting
CC       slightly darker coat pigmentation and a decreased proportion of auchene
CC       and zigzag hairs (PubMed:11094083). The mild phenotype is due to
CC       functional redundancy with other Sox genes (PubMed:11094083,
CC       PubMed:16895970). The phenotype apparently depends on the genetic
CC       context: backcrossing the mutant into a pure C57BL/6 background leads
CC       to defective lymphangiogenesis and the same embryonic lethality as
CC       observed for opossum mutants (PubMed:18931657).
CC       {ECO:0000269|PubMed:11094083, ECO:0000269|PubMed:16895970,
CC       ECO:0000269|PubMed:18931657}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L35032; AAB18615.1; -; mRNA.
DR   EMBL; AF288518; AAG48578.1; -; Genomic_DNA.
DR   EMBL; AK144281; BAE25811.1; -; mRNA.
DR   EMBL; BC006612; AAH06612.1; -; mRNA.
DR   EMBL; L29086; AAA56844.1; -; mRNA.
DR   CCDS; CCDS17218.1; -.
DR   RefSeq; NP_033262.2; NM_009236.2.
DR   PDB; 4Y60; X-ray; 1.75 A; C=77-155.
DR   PDBsum; 4Y60; -.
DR   AlphaFoldDB; P43680; -.
DR   SMR; P43680; -.
DR   BioGRID; 203404; 1.
DR   STRING; 10090.ENSMUSP00000062759; -.
DR   BindingDB; P43680; -.
DR   ChEMBL; CHEMBL4523228; -.
DR   iPTMnet; P43680; -.
DR   PhosphoSitePlus; P43680; -.
DR   MaxQB; P43680; -.
DR   PaxDb; P43680; -.
DR   PRIDE; P43680; -.
DR   ProteomicsDB; 261555; -.
DR   Antibodypedia; 15501; 178 antibodies from 28 providers.
DR   DNASU; 20672; -.
DR   Ensembl; ENSMUST00000054491; ENSMUSP00000062759; ENSMUSG00000046470.
DR   GeneID; 20672; -.
DR   KEGG; mmu:20672; -.
DR   UCSC; uc008ona.1; mouse.
DR   CTD; 54345; -.
DR   MGI; MGI:103559; Sox18.
DR   VEuPathDB; HostDB:ENSMUSG00000046470; -.
DR   eggNOG; KOG0527; Eukaryota.
DR   GeneTree; ENSGT00940000162709; -.
DR   HOGENOM; CLU_044994_1_0_1; -.
DR   InParanoid; P43680; -.
DR   OMA; HNLSQPC; -.
DR   OrthoDB; 1042753at2759; -.
DR   PhylomeDB; P43680; -.
DR   BioGRID-ORCS; 20672; 3 hits in 75 CRISPR screens.
DR   PRO; PR:P43680; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   RNAct; P43680; protein.
DR   Bgee; ENSMUSG00000046470; Expressed in kidney vasculature and 222 other tissues.
DR   Genevisible; P43680; MM.
DR   GO; GO:0000785; C:chromatin; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription regulator complex; IDA:MGI.
DR   GO; GO:0003677; F:DNA binding; IDA:MGI.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:MGI.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:MGI.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IDA:MGI.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:MGI.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:MGI.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; IDA:MGI.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; IBA:GO_Central.
DR   GO; GO:0001525; P:angiogenesis; IGI:MGI.
DR   GO; GO:0001568; P:blood vessel development; IMP:MGI.
DR   GO; GO:0043534; P:blood vessel endothelial cell migration; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0048469; P:cell maturation; IDA:MGI.
DR   GO; GO:0035050; P:embryonic heart tube development; IGI:MGI.
DR   GO; GO:0060956; P:endocardial cell differentiation; IGI:MGI.
DR   GO; GO:0060214; P:endocardium formation; IGI:MGI.
DR   GO; GO:0061028; P:establishment of endothelial barrier; ISO:MGI.
DR   GO; GO:0022405; P:hair cycle process; ISO:MGI.
DR   GO; GO:0001942; P:hair follicle development; IMP:MGI.
DR   GO; GO:0007507; P:heart development; IMP:MGI.
DR   GO; GO:0001701; P:in utero embryonic development; IMP:MGI.
DR   GO; GO:0001945; P:lymph vessel development; IMP:MGI.
DR   GO; GO:0001946; P:lymphangiogenesis; IMP:MGI.
DR   GO; GO:0060836; P:lymphatic endothelial cell differentiation; IMP:MGI.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:MGI.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:MGI.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:MGI.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0072091; P:regulation of stem cell proliferation; IDA:MGI.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:MGI.
DR   GO; GO:0048866; P:stem cell fate specification; IDA:MGI.
DR   GO; GO:0001944; P:vasculature development; IMP:MGI.
DR   GO; GO:0001570; P:vasculogenesis; IGI:MGI.
DR   Gene3D; 1.10.30.10; -; 1.
DR   InterPro; IPR009071; HMG_box_dom.
DR   InterPro; IPR036910; HMG_box_dom_sf.
DR   InterPro; IPR033392; Sox7/17/18_central.
DR   InterPro; IPR021934; Sox_C.
DR   Pfam; PF00505; HMG_box; 1.
DR   Pfam; PF12067; Sox17_18_mid; 1.
DR   SMART; SM00398; HMG; 1.
DR   SUPFAM; SSF47095; SSF47095; 1.
DR   PROSITE; PS50118; HMG_BOX_2; 1.
DR   PROSITE; PS51516; SOX_C; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; DNA-binding; Nucleus; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN           1..377
FT                   /note="Transcription factor SOX-18"
FT                   /id="PRO_0000048768"
FT   DOMAIN          256..376
FT                   /note="Sox C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00849"
FT   DNA_BIND        79..147
FT                   /note="HMG box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00267,
FT                   ECO:0000269|PubMed:26939885"
FT   REGION          1..76
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          81..94
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000269|PubMed:26939885"
FT   REGION          105..117
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000269|PubMed:26939885"
FT   REGION          160..225
FT                   /note="Important for transcriptional activation"
FT                   /evidence="ECO:0000269|PubMed:10742113,
FT                   ECO:0000269|PubMed:7651823"
FT   MOTIF           318..326
FT                   /note="9aaTAD"
FT                   /evidence="ECO:0000250|UniProtKB:P35713"
FT   CONFLICT        14
FT                   /note="P -> Q (in Ref. 4; BAE25811)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        156
FT                   /note="A -> E (in Ref. 1; AAB18615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        260
FT                   /note="A -> G (in Ref. 1; AAB18615)"
FT                   /evidence="ECO:0000305"
FT   HELIX           85..100
FT                   /evidence="ECO:0007829|PDB:4Y60"
FT   HELIX           106..119
FT                   /evidence="ECO:0007829|PDB:4Y60"
FT   HELIX           122..142
FT                   /evidence="ECO:0007829|PDB:4Y60"
SQ   SEQUENCE   377 AA;  40898 MW;  29F4C9B9D50F94D0 CRC64;
     MQRSPPGYGA QDDPPSRRDC AWAPGIGAAA EARGLPVTNV SPTSPASPSS LPRSPPRSPE
     SGRYGFGRGE RQTADELRIR RPMNAFMVWA KDERKRLAQQ NPDLHNAVLS KMLGKAWKEL
     NTAEKRPFVE EAERLRVQHL RDHPNYKYRP RRKKQARKVR RLEPGLLLPG LVQPSAPPEA
     FAAASGSARS FRELPTLGAE FDGLGLPTPE RSPLDGLEPG EASFFPPPLA PEDCALRAFR
     APYAPELARD PSFCYGAPLA EALRTAPPAA PLAGLYYGTL GTPGPFPNPL SPPPESPSLE
     GTEQLEPTAD LWADVDLTEF DQYLNCSRTR PDATTLPYHV ALAKLGPRAM SCPEESSLIS
     ALSDASSAVY YSACISG
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024